These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 11122388)

  • 1. Frequency of inhibitor development in severe haemophilia A children treated with cryoprecipitate and low-dose immune tolerance induction.
    ElAlfy MS; Tantawy AA; Ahmed MH; Abdin IA
    Haemophilia; 2000 Nov; 6(6):635-8. PubMed ID: 11122388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First prospective report on immune tolerance in poor risk haemophilia A inhibitor patients with a single factor VIII/von Willebrand factor concentrate in an observational immune tolerance induction study.
    Kreuz W; Escuriola Ettingshausen C; Vdovin V; Zozulya N; Plyushch O; Svirin P; Andreeva T; Bubanská E; Campos M; Benedik-Dolničar M; Jiménez-Yuste V; Kitanovski L; Klukowska A; Momot A; Osmulskaya N; Prieto M; Šalek SZ; Velasco F; Pavlova A; Oldenburg J; Knaub S; Jansen M; Belyanskaya L; Walter O; ;
    Haemophilia; 2016 Jan; 22(1):87-95. PubMed ID: 26202305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful low dose immune tolerance induction in severe haemophilia A with inhibitors below 40 Bethesda Units.
    Ter Avest PC; Fischer K; Gouw SC; Van Dijk K; Mauser-Bunschoten EP
    Haemophilia; 2010 May; 16(102):71-9. PubMed ID: 20536988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors.
    Unuvar A; Warrier I; Lusher JM
    Haemophilia; 2000 May; 6(3):150-7. PubMed ID: 10792472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purity of factor VIII product and incidence of inhibitors in previously untreated patients with haemophilia A.
    Mauser-Bunschoten EP; van der Bom JG; Bongers M; Twijnstra M; Roosendaal G; Fischer K; van den Berg HM
    Haemophilia; 2001 Jul; 7(4):364-8. PubMed ID: 11442640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immune tolerance induction with high-dose FVIII and pulsed intravenous immunoglobulin].
    Stiefel M; Pinkwart C; Haase R; Merkel N; Forsberg D; Mauz-Körholz C
    Hamostaseologie; 2010 Nov; 30 Suppl 1():S119-21. PubMed ID: 21042665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early eradication of factor VIII inhibitor in patients with congenital hemophilia A by immune tolerance induction with a high dose of immunoglobulin.
    Mizoguchi Y; Furue A; Kagawa R; Chijimatsu I; Tomioka K; Shimomura M; Imanaka Y; Nishimura S; Saito S; Miki M; Ono A; Konishi N; Kawaguchi H; Kobayashi M
    Int J Hematol; 2016 Apr; 103(4):473-7. PubMed ID: 26830966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of immune tolerance with recombinant factor VIII in haemophilia A patients with inhibitors.
    Batlle J; Lopez MF; Brackmann HH; Gaillard S; Goudemand J; Humbert J; De Moerloose P; Maass E; Mauz-Körholz C; Sultan Y; Stieltjes N
    Haemophilia; 1999 Nov; 5(6):431-5. PubMed ID: 10583531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors.
    Unuvar A; Kavakli K; Baytan B; Kazanci E; Sayli T; Oren H; Celkan T; Gursel T
    Haemophilia; 2008 Mar; 14(2):315-22. PubMed ID: 18081830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune tolerance induction in haemophilia A patients with inhibitors by treatment with recombinant factor VIII: a retrospective non-interventional study.
    Rivard GE; Rothschild C; Toll T; Achilles K
    Haemophilia; 2013 May; 19(3):449-55. PubMed ID: 23510123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prompt immune tolerance induction at inhibitor diagnosis regardless of titre may increase overall success in haemophilia A complicated by inhibitors: experience of two U.S. centres.
    Nakar C; Manco-Johnson MJ; Lail A; Donfield S; Maahs J; Chong Y; Blades T; Shapiro A
    Haemophilia; 2015 May; 21(3):365-373. PubMed ID: 25581638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.
    Mancuso ME; Fischer K; Santagostino E; Oldenburg J; Platokouki H; Königs C; Escuriola-Ettingshausen C; Rivard GE; Cid AR; Carcao M; Ljung R; Petrini P; Altisent C; Kenet G; Liesner R; Kurnik K; Auerswald G; Chambost H; Mäkipernaa A; Molinari AC; Williams M; van den Berg HM;
    Thromb Haemost; 2017 Dec; 117(12):2274-2282. PubMed ID: 29212115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune tolerance induction in haemophilia A patients with high-responding inhibitors to factor VIII: experience at a single institution.
    Rocino A; Papa ML; Salerno E; Capasso F; Miraglia E; de Biasi R
    Haemophilia; 2001 Jan; 7(1):33-8. PubMed ID: 11136378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune tolerance induction with a high purity von Willebrand factor/VIII complex concentrate in haemophilia A patients with inhibitors at high risk of a poor response.
    Gringeri A; Musso R; Mazzucconi MG; Piseddu G; Schiavoni M; Pignoloni P; Mannucci PM;
    Haemophilia; 2007 Jul; 13(4):373-9. PubMed ID: 17610550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of immune tolerance induction with Haemate P in haemophilia A.
    Escuriola Ettingshausen C; Kreuz W
    Haemophilia; 2014 May; 20(3):333-9. PubMed ID: 24165472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune tolerance in hemophilia with factor VIII inhibitors: predictors of success.
    Mariani G; Kroner B;
    Haematologica; 2001 Nov; 86(11):1186-93. PubMed ID: 11694405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Haemate(®) P as immune tolerance induction in patients with severe haemophilia A who failed previous induction attempts: a multicentre observational study.
    Rothschild C; D'Oiron R; Borel-Derlon A; Gruel Y; Navarro R; Negrier C
    Haemophilia; 2013 Mar; 19(2):281-6. PubMed ID: 23038998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.
    Bray GL; Gomperts ED; Courter S; Gruppo R; Gordon EM; Manco-Johnson M; Shapiro A; Scheibel E; White G; Lee M
    Blood; 1994 May; 83(9):2428-35. PubMed ID: 8167332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and risk factors for inhibitor development in previously untreated severe haemophilia A patients born between 2005 and 2010.
    Vézina C; Carcao M; Infante-Rivard C; Lillicrap D; Stain AM; Paradis E; Teitel J; Rivard GE;
    Haemophilia; 2014 Nov; 20(6):771-6. PubMed ID: 25039669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.